Fuel Clinical Leads Successful Strategic Planning and Execution of Large U.S. Multi-Site Endocrinology Registry
Integrated clinical operations, biometrics and data strategy drive successful execution across more than 10 U.S. research sites and nearly 200 subjects
Published: June 2026
TORONTO — Fuel Clinical today announced the successful management and execution of a large U.S. multi-site registry within the endocrinology and hormone-related therapeutic space, demonstrating the value of integrating clinical strategy, operations, biometrics and technology around a clearly defined study objective.
The registry included more than 10 clinical research sites across the United States and enrolled nearly 200 subjects.
Fuel played an integral role across the program, driving protocol development, database strategy and design, clinical operations, site management, subject enrollment and Data Management.
From the beginning, the program was approached with the end in mind.
Rather than treating protocol development, study execution and data collection as separate activities, Fuel aligned the clinical and operational strategy with the information ultimately required for analysis and publication. This allowed decisions made during study design and execution to remain connected to the long-term scientific value of the registry.
Large registry programs are not simply enrollment exercises. You have to understand what you ultimately want to learn from the data and then work backward from that objective. The protocol, database, site strategy, operational execution and data strategy all need to connect. That is exactly what we mean by Unified Intelligence.
Andrew Schachter
|Founder & CEO, Fuel Clinical
Managing a multi-site registry requires consistent execution across investigative sites while maintaining data quality, operational visibility and alignment with the scientific objectives of the program.
Fuel coordinated activities across the participating sites while maintaining an integrated view of enrollment, study conduct and data collection. That cross-functional approach allowed operational and data considerations to be addressed together rather than independently.
For Fuel, the objective was not simply to enroll subjects and collect information. It was to create a dataset capable of delivering meaningful long-term value.
From the beginning, it was important that the data strategy and registry design aligned not only with the immediate operational requirements of the study, but also with the long-term analysis and publication objectives. When you define those requirements early, you can design the database and data collection strategy around the questions the sponsor ultimately wants to answer.
Erika Passi
|Global Head of Biometrics, Fuel Clinical
The program also demonstrates the importance of bringing Clinical Operations and Biometrics together early in study planning.
Site execution determines whether critical information is collected correctly and consistently. Data Management determines whether that information can be reviewed, reconciled and transformed into usable data. Biometrics helps ensure the information being generated can ultimately address the intended scientific and analytical objectives.
Connecting those disciplines from the beginning reduces the risk of discovering late in a program that important information was missing, inconsistently collected or not structured appropriately for the intended analyses.
This philosophy is central to Fuel Clinical's Unified Intelligence model: start with the desired outcome, identify the clinical, operational, biometrics, data and technology requirements necessary to reach it, and then execute the study around that shared objective.
The value of a registry is ultimately determined by what you can do with the information it generates. Successful execution is important, but successful execution combined with the right data strategy creates something much more valuable: information that can continue generating clinical and scientific insight long after enrollment has ended.
Andrew Schachter
|Founder & CEO, Fuel Clinical
Fuel Clinical recognizes the sponsor, investigators, coordinators, research teams and patients whose participation and collaboration made the program possible.
About Fuel Clinical
Fuel Clinical's services begin with Unified Intelligence Strategic Planning, helping sponsors start with the end in mind by defining the clinical, operational, biometrics, data and technology strategy required to achieve a successful study outcome.
From that foundation, Fuel provides integrated Clinical Development and Clinical Operations, Data Management, Biostatistics and Statistical Programming, Data Analytics, Safety and Pharmacovigilance, and a comprehensive suite of eClinical technologies including EDC, RTSM/IWRS, CTMS, eTMF, ePRO/eCOA, Safety Database and Clinical Trial Payments solutions.
Through its Unify platform, Fuel connects these capabilities and critical study data within a coordinated environment, giving sponsors greater visibility into study performance and the information required to make timely, informed decisions throughout development.